Through interfering with some of the network components, we identified conditions in which interventions to prevent metastasis in a model breast cancer could work (or not) [39], and suggested combination therapy for nucleophosmin anaplastic lymphoma kinase (NPM-ALK) derived anaplastic large cell lymphomas [40]. The gene discussed is ALK; the disease is breast carcinoma.